Effects of atypical κ-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 1, 2009, Pages 193-200

  Ko, Mei Chuan ^a,b,c   Husbands, Stephen M ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b University of Bath   (United Kingdom)

^c NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; BREMAZOCINE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; NALFURAFINE; NORBINALTORPHIMINE; BENZOMORPHAN DERIVATIVE; KAPPA OPIATE RECEPTOR; MORPHINAN DERIVATIVE; PIPERAZINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SPIRO COMPOUND;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG STRUCTURE; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; RHESUS MONKEY; SCRATCHING; SEDATION; TREATMENT RESPONSE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EXERCISE; HEAT; INTRASPINAL DRUG ADMINISTRATION; MACACA; NERVE CELL; PHYSIOLOGY; REACTION TIME; STATISTICS;

ANALGESIA; ANIMALS; BENZOMORPHANS; FEMALE; HOT TEMPERATURE; INJECTIONS, SPINAL; MACACA MULATTA; MALE; MORPHINANS; MORPHINE; NEURONS; PIPERAZINES; PYRROLIDINES; REACTION TIME; RECEPTORS, OPIOID, KAPPA; RESTRAINT, PHYSICAL; SPIRO COMPOUNDS;

EID: 58849139249     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.143925     Document Type: Article

References (40)

1. Bailey PL, Rhondeau S, Schafer PG, Lu JK, Timmins BS, Foster W, Pace NL, and Stanley TH (1993) Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology 79:49-59.
2. Butelman ER, Ko MC, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, and Woods JH (1998) Kappa-opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. J Pharmacol Exp Ther 285:595-601.
3. Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, and Woods JH (2001) GR89,696: a potent κ-opioid agonist with subtype selectivity in rhesus monkeys. JPharmacol Exp Ther 298:1049-1059.
4. Butelman ER, Negus SS, Ai Y, de Costa BR, and Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267:1269-1276.
5. Cohen SE, Ratner EF, Kreitzman TR, Archer JH, and Mignano LR (1992) Nalbu-phine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg 75:747-752.
6. Cousins MJ and Mather LE (1984) Intrathecal and epidural administration of opioids. Anesthesiology 61:276-310.
7. Cowan A and Gmerek DE (1986) In vivo studies on kappa opioid receptors. Trends Pharmacol Sci 7:69 -72.
8. Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, and Giesler GJ Jr (2007) The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 27:10007-10014.
9. DeBalli P and Breen TW (2003) Intrathecal opioids for combined spinal-epidural analgesia during labour. CNS Drugs 17:889 -904.
10. Emmerson PJ, Liu MR, Woods JH, and Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. JPharmacol Exp Ther 271:1630-1637.
11. Endoh T, Tajima A, Izumimoto N, Suzuki T, Saitoh A, Suzuki T, Narita M, Kamei J, Tseng LF, Mizoguchi H, et al. (2001) TRK-820, a selective K-opioid agonist, produces potent antinociception in cynomolgus monkeys. Jpn J Pharmacol 85:282-290.
12. France CP, Medzihradsky F, and Woods JH (1994) Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities. J Pharmacol Exp Ther 268:47-58.
13. Ganesh A and Maxwell LG (2007) Pathophysiology and management of opioid-induced pruritus. Drugs 67:2323-2333.
14. Gmerek DE, Dykstra LA, and Woods JH (1987) Kappa opioids in rhesus monkeys: III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428-436.
15. Heishman SJ, Stitzer ML, Bigelow GE, and Liebson IA (1989) Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. J Pharmacol Exp Ther 248:127-134.
16. Inan S and Cowan A (2006) Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol Biochem Behav 85:39 -43.
17. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council and National Academy Press, Washington, DC.
18. Kamei J and Nagase H (2001) Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 418: 141-145.
19. Kishioka S, Paronis CA, and Woods JH (2000) Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys. Eur J Pharmacol 398:121-130.
20. 2 analysis in rhesus monkeys. J Pharmacol Exp Ther 285:518-526.
21. Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, and Woods JH (1999) Intracisternal nor-binaltorphimine distinguishes central and peripheral κ-opioid antinociception in rhesus monkeys. J Pharmacol Exp Ther 291:1113-1120.
22. Ko MCH and Naughton NN (2000) An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology 92:795-805.
23. Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, and Naughton NN (2003a) Activation of K-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. J Pharmacol Exp Ther 305:173-179.
24. Ko MC, Willmont KJ, Lee H, Flory GS, and Woods JH (2003b) Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Res 982:38-44.
25. Ko MC, Song MS, Edwards T, Lee H, and Naughton NN (2004) The role of central μ opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther 310: 169-176.
26. Lee H, Naughton NN, Woods JH, and Ko MCH (2003) Characterization of scratching responses in rats following centrally administered morphine or bombesin. Behav Pharmacol 14:501-508.
27. Lee H, Naughton NN, Woods JH, and Ko MC (2007) Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology 107:478-485.
28. Li J, Li JG, Chen C, Zhang F, and Liu-Chen LY (2002) Molecular basis of differences in ( -)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)- cyclohexyl]benzeneacet- amide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in chinese hamster ovary cells. Mol Pharmacol 61:73-84.
29. Liu-Chen LY (2004) Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci 75:511-536. Mizoguchi H, Hung KC, Leitermann R, Narita M, Nagase H, Suzuki T, and Tseng LF (2003) Blockade of μ-opioid receptor-mediated G-protein activation and antinoci-ception by TRK-820 in mice. Eur J Pharmacol 461:35-39.
30. Palmer CM, Emerson S, Volgoropolous D, and Alves D (1999) Dose-response relationship of intrathecal morphine for postcesarean analgesia. Anesthesiology 90: 437-444.
31. Rawal N, Schött U, Dahlström B, Inturrisi CE, Tandon B, Sjöstrand U, and Wennhager M (1986) Influence ofnaloxone infusion on analgesia and respiratory depression following epidural morphine. Anesthesiology 64:194-201.
32. Simonin F, Gavériaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattéi MG, Charron G, Bloch B, and Kieffer B (1995) κ-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci USA92:7006-7010.
33. Tallarida RJ(2000) DrugSynergismandDose-EffectDataAnalysis, CRC Press, Boca Raton, FL.
34. Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, et al. (2002) Antipruritic activity of the κ-opioid receptor agonist, TRK-820. Eur JPharmacol 435:259-264.
35. Toll L, Berzetei-Gurske IP, Polgar WE, Brandt SR, Adapa ID, Rodriguez L, Schwartz RW, Haggart D, O'Brien A, White A, et al. (1998) Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res Monogr 178:440 -466.
36. Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, and Nagase H (2003) Involvement of central u-opioid system in the scratching behavior in mice, and the suppression ofit by the activation ofK-opioid system. Eur J Pharmacol 477:29-35.
37. Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T, and Nagase H (2004) Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sci 75:2947-2957.
38. Wang JJ, Ho ST, and Tzeng JI (1998) Comparison of intravenous nalbuphineinfusion versus naloxone in the prevention of epidural morphine-related side effects. Reg Anesth Pain Med 23:479 -484.
39. Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, and Liu-Chen LY (2005) Comparison of pharmacologic activities of three distinct κ ligands (salvinorin A, TRK-820 and 3FLB) on κ opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 312:220 -230.
40. Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, et al. (2005) Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blinded, placebo-controlled clinical studies. J Am Soc Nephrol 16:3742-3747.